Treatment for selective weight control

作者: George A. Bray , Frank L. Greenway

DOI:

关键词:

摘要: A treatment for accelerating regional weight reduction in humans, wherein an active ingredient encouraging elimination of fatty deposits, preferably a beta adrenergic stimulator or alpha-2 inhibitor, is selectively delivered to fat deposit prior commencing during general control program, whereby body preferentially reduced the selected area. The stimulator, isoproterenol forskolin, yohimbine, combinations thereof may be by any means accomplishing specific delivery area, including injection, implantation, and topical application skin as ointment creme.

参考文章(10)
Per Björntorp, Jan Östman, Human Adipose Tissue Dynamics and Regulation Advances in metabolic disorders. ,vol. 5, pp. 277- 327 ,(1971) , 10.1016/B978-0-12-027305-8.50027-8
John R. Hughes, The pharmacological basis of therapeutics, 6th edition Electroencephalography and Clinical Neurophysiology. ,vol. 52, pp. 504- ,(1981) , 10.1016/0013-4694(81)90038-9
Clifton A. Baile, Roger C. Parish, William D. Kingsbury, Methods for improving the feed intake of meat producing animals ,(1972)
Patrick Darmenton, Constantin Koulbanis, Claude Bouillon, Cosmetic compositions having a slimming action ,(1979)
Frank L Bigsby, Appetite control composition ,(1960)
Jan Östman, Peter Arner, Peter Engfeldt, Lars Kager, Regional differences in the control of lipolysis in human adipose tissue. Metabolism-clinical and Experimental. ,vol. 28, pp. 1198- 1205 ,(1979) , 10.1016/0026-0495(79)90131-8